Bolt Biotherapeutics, Inc. - BOLT
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | Chief Operating Officer | S | D | 6,850.0 | 3.2364 | 22,169.34 | 17,269.0 | View | |
| Sep 21, 2026 | Chief Operating Officer | S | D | 4,909.0 | 3.3183 | 16,289.53 | 24,119.0 | View | |
| Sep 21, 2026 | Chief Operating Officer | S | D | 1,417.0 | 3.774 | 5,347.76 | 29,028.0 | View | |
| Sep 21, 2026 | Senior VP, Finance and PAO | S | D | 4,077.0 | 3.2364 | 13,194.8 | 17,082.0 | View | |
| Sep 21, 2026 | Senior VP, Finance and PAO | S | D | 2,922.0 | 3.3183 | 9,696.07 | 21,159.0 | View | |
| Sep 21, 2026 | Senior VP, Finance and PAO | S | D | 843.0 | 3.774 | 3,181.48 | 24,081.0 | View | |
| Sep 21, 2026 | Senior VP, Finance and PAO | P | A | 509.0 | 3.876 | 1,972.88 | 1,924.0 | View | |
| Sep 21, 2026 | President, CEO and CFO | S | D | 9,132.0 | 3.2364 | 29,554.8 | 25,384.0 | View | |
| Sep 21, 2026 | President, CEO and CFO | S | D | 6,545.0 | 3.3183 | 21,718.27 | 34,516.0 | View | |
| Sep 21, 2026 | President, CEO and CFO | S | D | 1,889.0 | 3.774 | 7,129.09 | 41,061.0 | View | |
| Sep 21, 2026 | President, CEO and CFO | P | A | 637.0 | 3.876 | 2,469.01 | 2,950.0 | View | |
| Jun 11, 2026 | — | A | A | 5,000.0 | 0.0 | 0.0 | 5,000.0 | View | |
| Jun 11, 2026 | — | A | A | 5,000.0 | 0.0 | 0.0 | 5,000.0 | View | |
| Jun 11, 2026 | — | A | A | 5,000.0 | 0.0 | 0.0 | 5,000.0 | View | |
| Jun 11, 2026 | — | A | A | 5,000.0 | 0.0 | 0.0 | 5,000.0 | View | |
| Jun 11, 2026 | — | A | A | 5,000.0 | 0.0 | 0.0 | 5,000.0 | View |